154 related articles for article (PubMed ID: 35166957)
1. Aspirin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma.
Holmberg D; Kauppila JH; Mattsson F; Asplund J; Leijonmarck W; Xie SH; Lagergren J
Gastric Cancer; 2022 May; 25(3):652-658. PubMed ID: 35166957
[TBL] [Abstract][Full Text] [Related]
2. Statin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma: a Swedish population-based cohort study.
Holmberg D; Kauppila JH; Asplund J; Leijonmarck W; Mattsson F; Lagergren J
Gastric Cancer; 2024 May; 27(3):590-597. PubMed ID: 38430275
[TBL] [Abstract][Full Text] [Related]
3. Weekday of gastrectomy and long-term survival in gastric adenocarcinoma.
Leijonmarck W; Asplund J; Markar SR; Mattsson F; Lagergren J
Eur J Surg Oncol; 2023 Jan; 49(1):83-88. PubMed ID: 35922280
[TBL] [Abstract][Full Text] [Related]
4. Prognosis after surgery for gastric adenocarcinoma in the Swedish Gastric Cancer Surgery Study (SWEGASS).
Asplund J; Gottlieb-Vedi E; Leijonmarck W; Mattsson F; Lagergren J
Acta Oncol; 2021 Apr; 60(4):513-520. PubMed ID: 33502275
[TBL] [Abstract][Full Text] [Related]
5. Annual surgeon and hospital volume of gastrectomy and gastric adenocarcinoma survival in a population-based cohort study.
Asplund J; Mattsson F; Plecka-Östlund M; Markar SR; Lagergren J
Acta Oncol; 2022 Apr; 61(4):425-432. PubMed ID: 35023804
[TBL] [Abstract][Full Text] [Related]
6. Surgeon age in relation to patients' long-term survival after gastrectomy for gastric adenocarcinoma: nationwide population-based cohort study.
Leijonmarck W; Mattsson F; Asplund J; Markar S; Lagergren J
BJS Open; 2024 Mar; 8(2):. PubMed ID: 38669194
[TBL] [Abstract][Full Text] [Related]
7. Aspirin or statin use in relation to survival after surgery for esophageal cancer: a population-based cohort study.
Holmberg D; Gottlieb-Vedi E; Hedberg J; Lindblad M; Mattsson F; Lagergren J
BMC Cancer; 2023 Apr; 23(1):375. PubMed ID: 37098462
[TBL] [Abstract][Full Text] [Related]
8. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
9. [Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment].
Wang TB; Mao QK; Zhang XJ; Zhou H; Guo CG; Chen YT; Zhao DB
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):160-166. PubMed ID: 33508922
[No Abstract] [Full Text] [Related]
10. Surgeon proficiency gain and survival after gastrectomy for gastric adenocarcinoma: A population-based cohort study.
Asplund JPU; Mackenzie HA; Markar SR; Lagergren JHF
Eur J Cancer; 2023 Jun; 186():91-97. PubMed ID: 37062212
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy.
Badgwell B; Blum M; Estrella J; Chiang YJ; Das P; Matamoros A; Fournier K; Mansfield P; Ajani J
J Am Coll Surg; 2015 Jul; 221(1):83-90. PubMed ID: 26002780
[TBL] [Abstract][Full Text] [Related]
12. Improved prognosis in gastric adenocarcinoma among metformin users in a population-based study.
Zheng J; Santoni G; Xie SH; Lagergren J
Br J Cancer; 2021 Jul; 125(2):277-283. PubMed ID: 33972744
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
Cheng X; Wu D; Xu N; Chen L; Yan Z; Chen P; Zhou L; Yu J; Cui J; Li W; Wang C; Feng W; Wei Y; Yu P; Du Y; Ying J; Xu Z; Yang L; Zhang Y
BMC Cancer; 2021 Jan; 21(1):56. PubMed ID: 33435909
[TBL] [Abstract][Full Text] [Related]
14. Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study.
Zheng J; Xie SH; Santoni G; Lagergren J
Br J Cancer; 2019 Nov; 121(10):877-882. PubMed ID: 31591459
[TBL] [Abstract][Full Text] [Related]
15. [Long-term efficacy of robotic radical total gastrectomy for gastric cancer and analysis of prognostic factors].
Xie SH; Shi Y; Long D; Chen J; Zhao YL; Qian F; Hao YX; Tang B; Li PA; Yu PW
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):357-363. PubMed ID: 32306603
[No Abstract] [Full Text] [Related]
16. Use of 5α-reductase inhibitors and survival of oesophageal and gastric cancer in a nationwide Swedish cohort study.
Rabbani S; Mattsson F; Lagergren J; Xie S
Acta Oncol; 2023 May; 62(5):438-443. PubMed ID: 37216488
[TBL] [Abstract][Full Text] [Related]
17. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
18. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP
BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229
[TBL] [Abstract][Full Text] [Related]
19. Interaction of Postoperative Morbidity and Receipt of Adjuvant Therapy on Long-Term Survival After Resection for Gastric Adenocarcinoma: Results From the U.S. Gastric Cancer Collaborative.
Jin LX; Sanford DE; Squires MH; Moses LE; Yan Y; Poultsides GA; Votanopoulos KI; Weber SM; Bloomston M; Pawlik TM; Hawkins WG; Linehan DC; Schmidt C; Worhunsky DJ; Acher AW; Cardona K; Cho CS; Kooby DA; Levine EA; Winslow E; Saunders N; Spolverato G; Colditz GA; Maithel SK; Fields RC
Ann Surg Oncol; 2016 Aug; 23(8):2398-408. PubMed ID: 27006126
[TBL] [Abstract][Full Text] [Related]
20. Impact of minimally invasive gastrectomy on use of and time to adjuvant chemotherapy for gastric adenocarcinoma.
Farrow NE; Freischlag KW; Adam MA; Blazer DG
J Surg Oncol; 2020 Mar; 121(3):486-493. PubMed ID: 31919862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
